TrialBMC cancer2009

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers.

Loukas F Kontovinis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.